Page last updated: 2024-08-16

meptazinol and Amentia

meptazinol has been researched along with Amentia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HZ; Ge, XX; Jiang, P; Le, WD; Lu, Y; Qiu, ZB; Shao, BY; Sun, J; Wang, H; Xia, Z; Xie, Q; Zhang, WW1

Other Studies

1 other study(ies) available for meptazinol and Amentia

ArticleYear
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.
    CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:2

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Cell Line, Tumor; Cholinesterase Inhibitors; Dementia; Disease Models, Animal; Drug Administration Schedule; Humans; Maze Learning; Meptazinol; Mice; Mice, Transgenic; Neuroblastoma; Phenylcarbamates; Presenilin-1; RNA, Messenger; Scopolamine

2014